In comparison to the high-risk group, the low-risk group exhibits significantly increased infiltration of B cells, CD8 T cells, activated CD4 T cells, follicular helper T cells (Tfh), regulatory T cells (Tregs), and resting mast cells in tumor tissues. This evidence concerns the gene CD4 and neoplasm.